This week on Careers in Discovery, we’re joined by Remi-Martin Laberge, Co-founder and Chief Technology Officer of Arda Therapeutics. Remi shares his journey from academic research to building companies, the lessons he learned at Unity Biotechnology, and how Arda is using single-cell sequencing and targeted antibodies to eliminate disease-driving cells in chronic conditions. We talked about the leap from scientist to founder, applying oncology tools beyond cancer, and why curiosity and risk-taking go hand in hand in Biotech.